ClearCheck · Trials

import { wrapFetchWithPayment } from "@x402/fetch";
import { privateKeyToAccount } from "viem/accounts";

const account = privateKeyToAccount(process.env.PRIVATE_KEY);
const fetchWithPay = wrapFetchWithPayment(fetch, account);

const res = await fetchWithPay("https://loonie-toll.onrender.com/trials", {
  method: "GET",
});
const data = await res.json();

curl -X GET \
  "https://loonie-toll.onrender.com/trials?condition=melanoma" \
  -H "X-PAYMENT: <signed x402 payment>"

{
  "byPhase": [
    {
      "count": 36,
      "phase": "PHASE1"
    },
    {
      "count": 34,
      "phase": "PHASE2"
    }
  ],
  "byStatus": [
    {
      "count": 45,
      "status": "COMPLETED"
    },
    {
      "count": 14,
      "status": "TERMINATED"
    }
  ],
  "counts": {
    "examined": 100,
    "industrySponsored": 31,
    "lateStage": 5,
    "recruiting": 15,
    "totalEnrollmentAcrossExamined": 14106,
    "totalMatching": 3753
  },
  "disclaimer": "Advisory only, provided as is without warranty of accuracy or completeness. Trial records are submitted by sponsors and investigators and may be incomplete or out of date. This is not medical advice a…",
  "query": {
    "condition": "melanoma",
    "sponsor": null,
    "status": "ALL"
  },
  "retrievedAt": "2026-09-09T00:58:02.235Z",
  "signals": [
    "15 of the 100 trials examined are open to enrolment.",
    "5 are Phase 3 or 4 — late-stage, closest to approval.",
    "…2 more"
  ],
  "source": "ClinicalTrials.gov API v2 (NIH/NLM)",
  "topSponsors": [
    {
      "count": 8,
      "sponsor": "National Cancer Institute (NCI)"
    },
    {
      "count": 3,
      "sponsor": "Bristol-Myers Squibb"
    }
  ],
  "trials": [
    {
      "completionDate": "2022-12-27",
      "enrollment": 165,
      "leadSponsor": "OrienGene Biotechnology Ltd.",
      "nctId": "NCT04200040",
      "phases": [
        "PHASE2"
      ],
      "sponsorClass": "INDUSTRY",
      "startDate": "2017-08-27",
      "status": "UNKNOWN",
      "studyType": "INTERVENTIONAL",
      "title": "A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients"
    },
    {
      "completionDate": "2021-07-31",
      "enrollment": 0,
      "leadSponsor": "Brigham and Women's Hospital",
      "nctId": "NCT03548610",
      "phases": [
        "NA"
      ],
      "sponsorClass": "OTHER",
      "startDate": "2019-01-30",
      "status": "WITHDRAWN",
      "studyType": "INTERVENTIONAL",
      "title": "Efficacy and Safety of a Nanofat-seeded Biological Scaffold in Healing Lower Limb Surgical Defects"
    }
  ]
}